Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan

PHASE3CompletedINTERVENTIONAL

Enrollment

650

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

September 30, 2006

Conditions

Involutional Osteoporosis

Interventions

DRUG

ONO-5920

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Astellas Pharma Inc

INDUSTRY

lead

Ono Pharmaceutical Co. Ltd

INDUSTRY

NCT00212667 - Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan | Biotech Hunter | Biotech Hunter